Literature DB >> 24532493

Assessing skeletal muscle mass: historical overview and state of the art.

Steven B Heymsfield1, Michael Adamek, M Cristina Gonzalez, Guang Jia, Diana M Thomas.   

Abstract

BACKGROUND: Even though skeletal muscle (SM) is the largest body compartment in most adults and a key phenotypic marker of sarcopenia and cachexia, SM mass was until recently difficult and often impractical to quantify in vivo. This review traces the historical development of SM mass measurement methods and their evolution to advances that now promise to provide in-depth noninvasive measures of SM composition.
METHODS: Key steps in the advancement of SM measurement methods and their application were obtained from historical records and widely cited publications over the past two centuries. Recent advances were established by collecting information on notable studies presented at scientific meetings and their related publications.
RESULTS: The year 1835 marks the discovery of creatine in meat by Chevreul, a finding that still resonates today in the D3-creatine method of measuring SM mass. Matiegka introduced an anthropometric approach for estimating SM mass in 1921 with the vision of creating a human "capacity" marker. The 1940s saw technological advances eventually leading up to the development of ultrasound and bioimpedance analysis methods of quantifying SM mass in vivo. Continuing to seek an elusive SM mass "reference" method, Burkinshaw and Cohn introduced the whole-body counting-neutron activation analysis method and provided some of the first detailed reports of cancer cachexia in the late 1970s. Three transformative breakthroughs leading to the current SM mass reference methods appeared in the 1970s and early 1980s as follows: the introduction of computed tomography (CT), photon absorptiometry, and magnetic resonance (MR) imaging. Each is advanced as an accurate and/or practical approach to quantifying whole-body and regional SM mass across the lifespan. These advances have led to a new understanding of fundamental body size-SM mass relationships that are now widely applied in the evaluation and monitoring of patients with sarcopenia and cachexia. An intermediate link between SM mass and function is SM composition. Advances in water-fat MR imaging, diffusion tensor imaging, MR elastography, imaging of connective tissue structures by ultra-short echo time MR, and other new MR approaches promise to close the gap that now exists between SM anatomy and function.
CONCLUSIONS: The global efforts of scientists over the past two centuries provides us with highly accurate means by which to measure SM mass across the lifespan with new advances promising to extend these efforts to noninvasive methods for quantifying SM composition.

Entities:  

Year:  2014        PMID: 24532493      PMCID: PMC3953319          DOI: 10.1007/s13539-014-0130-5

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


  84 in total

1.  Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status.

Authors:  T B VanItallie; M U Yang; S B Heymsfield; R C Funk; R A Boileau
Journal:  Am J Clin Nutr       Date:  1990-12       Impact factor: 7.045

2.  Qualitative and quantitative ultrashort echo time (UTE) imaging of cortical bone.

Authors:  Jiang Du; Michael Carl; Mark Bydder; Atsushi Takahashi; Christine B Chung; Graeme M Bydder
Journal:  J Magn Reson       Date:  2010-09-25       Impact factor: 2.229

Review 3.  Fat and water magnetic resonance imaging.

Authors:  Thorsten A Bley; Oliver Wieben; Christopher J François; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2010-01       Impact factor: 4.813

4.  Fiber type characterization in skeletal muscle by diffusion tensor imaging.

Authors:  Michael Scheel; Philipp von Roth; Tobias Winkler; Adamantios Arampatzis; Torben Prokscha; Bernd Hamm; Gerd Diederichs
Journal:  NMR Biomed       Date:  2013-04-04       Impact factor: 4.044

5.  Determination of anatomical skeletal muscle mass by whole body nuclear magnetic resonance.

Authors:  O Selberg; W Burchert; G Graubner; C Wenner; C Ehrenheim; M J Müller
Journal:  Basic Life Sci       Date:  1993

6.  Nuclear magnetic resonance pulse sequence and discrimination of high- and low-fat tissues.

Authors:  M A Foster; J M Hutchison; J R Mallard; M Fuller
Journal:  Magn Reson Imaging       Date:  1984       Impact factor: 2.546

7.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

Authors:  A Kumar; R R Ernst; K Wüthrich
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

8.  Evaluation of healthy and diseased muscle with magnetic resonance elastography.

Authors:  Jeffrey R Basford; Thomas R Jenkyn; Kai-Nan An; Richard L Ehman; Guido Heers; Kenton R Kaufman
Journal:  Arch Phys Med Rehabil       Date:  2002-11       Impact factor: 3.966

9.  Scaling of body composition to height: relevance to height-normalized indexes.

Authors:  Steven B Heymsfield; Moonseong Heo; Diana Thomas; Angelo Pietrobelli
Journal:  Am J Clin Nutr       Date:  2011-01-19       Impact factor: 7.045

10.  Computed tomography of the human skeletal muscular system.

Authors:  J A Bulcke; J L Termote; Y Palmers; D Crolla
Journal:  Neuroradiology       Date:  1979-03-23       Impact factor: 2.804

View more
  57 in total

1.  Quantifying Sarcopenia Reference Values Using Lumbar and Thoracic Muscle Areas in a Healthy Population.

Authors:  B A Derstine; S A Holcombe; R L Goulson; B E Ross; N C Wang; J A Sullivan; G L Su; S C Wang
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

2.  Change in fatty infiltration of lumbar multifidus, erector spinae, and psoas muscles in asymptomatic adults of Asian or Caucasian ethnicities.

Authors:  Rebecca J Crawford; James M Elliott; Thomas Volken
Journal:  Eur Spine J       Date:  2017-07-11       Impact factor: 3.134

Review 3.  Assessment and definition of lean body mass deficiency in the elderly.

Authors:  M J Müller; C Geisler; M Pourhassan; C-C Glüer; A Bosy-Westphal
Journal:  Eur J Clin Nutr       Date:  2014-08-20       Impact factor: 4.016

4.  Validation of daily urinary creatinine excretion measurement by muscle-creatinine equivalence.

Authors:  Roberto Iacone; Lanfranco D'Elia; Bruna Guida; Antonio Barbato; Clelia Scanzano; Pasquale Strazzullo
Journal:  J Clin Lab Anal       Date:  2018-02-09       Impact factor: 2.352

5.  Lumbar muscle volume in postmenopausal women with osteoporotic compression fractures: quantitative measurement using MRI.

Authors:  Chi Wen C Huang; Ing-Jy Tseng; Shao-Wei Yang; Yen-Kuang Lin; Wing P Chan
Journal:  Eur Radiol       Date:  2019-03-07       Impact factor: 5.315

Review 6.  Recent Progress in Sarcopenia Research: a Focus on Operationalizing a Definition of Sarcopenia.

Authors:  Peggy M Cawthon
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

7.  Muscle profile and cognition in patients with Alzheimer's disease dementia.

Authors:  Yeonsil Moon; Ye-Ji Choi; Jin Ok Kim; Seol-Heui Han
Journal:  Neurol Sci       Date:  2018-08-06       Impact factor: 3.307

8.  Patient Height, Weight, BMI and Age as Predictors of Gracilis Muscle Free-Flap Mass in Lower Extremity Reconstruction.

Authors:  Carlo M Oranges; Mathias Tremp; Wenjin Wang; Srinivas Madduri; Pietro G DI Summa; Reto Wettstein; Dirk J Schaefer; Daniel F Kalbermatten
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

9.  Treatment to improve nutrition and functional capacity evaluation in liver transplant candidates.

Authors:  Srinivasan Dasarathy
Journal:  Curr Treat Options Gastroenterol       Date:  2014-06

10.  R3hdml regulates satellite cell proliferation and differentiation.

Authors:  Kenichi Sakamoto; Yasuro Furuichi; Masashi Yamamoto; Megumi Takahashi; Yoshihiro Akimoto; Takahiro Ishikawa; Takahiko Shimizu; Masanori Fujimoto; Aki Takada-Watanabe; Aiko Hayashi; Yoshitaka Mita; Yasuko Manabe; Nobuharu L Fujii; Ryoichi Ishibashi; Yoshiro Maezawa; Christer Betsholtz; Koutaro Yokote; Minoru Takemoto
Journal:  EMBO Rep       Date:  2019-09-16       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.